NDC Package 51759-202-11 Ajovy

Fremanezumab-vfrm Injection Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51759-202-11
Package Description:
1 CONTAINER in 1 CARTON / 1.5 mL in 1 CONTAINER
Product Code:
Proprietary Name:
Ajovy
Non-Proprietary Name:
Fremanezumab-vfrm
Substance Name:
Fremanezumab
Usage Information:
This medication is used to help prevent migraine. This medication may work by changing the amounts of certain natural substances in the brain. Fremanezumab-vfrm belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks.
11-Digit NDC Billing Format:
51759020211
NDC to RxNorm Crosswalk:
  • RxCUI: 2056695 - fremanezumab-vfrm 225 MG in 1.5 mL Prefilled Syringe
  • RxCUI: 2056695 - 1.5 ML fremanezumab-vfrm 150 MG/ML Prefilled Syringe
  • RxCUI: 2056695 - fremanezumab-vfrm 225 MG per 1.5 ML Prefilled Syringe
  • RxCUI: 2056700 - AJOVY 225 MG in 1.5 mL Prefilled Syringe
  • RxCUI: 2056700 - 1.5 ML fremanezumab-vfrm 150 MG/ML Prefilled Syringe [Ajovy]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Teva Pharmaceuticals Usa, Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    Yes
    FDA Application Number:
    BLA761089
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    03-29-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    51759-202-101 CONTAINER in 1 CARTON / 1.5 mL in 1 CONTAINER
    51759-202-223 CONTAINER in 1 CARTON / 1.5 mL in 1 CONTAINER

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51759-202-11?

    The NDC Packaged Code 51759-202-11 is assigned to a package of 1 container in 1 carton / 1.5 ml in 1 container of Ajovy, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is injection and is administered via subcutaneous form.

    Is NDC 51759-202 included in the NDC Directory?

    Yes, Ajovy with product code 51759-202 is active and included in the NDC Directory. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on March 29, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 51759-202-11?

    The 11-digit format is 51759020211. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-251759-202-115-4-251759-0202-11